REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
Company announced positive topline results from pivotal Phase III AFFINITY DUCHENNE® study of RGX-202 Primary endpoint achieved with high statistical significance... Read more.
Monport Marks Memorial Day With Savings on Laser Engraving Machines and Creative Tools
NEW YORK, May 14, 2026 /PRNewswire/ — As Memorial Day approaches, Monport Laser is recognizing the holiday with a campaign that highlights craftsmanship,... Read more.
Rochefort Provides Financing to Red 6 to Expand Military Augmented Reality Training
WEST PALM BEACH, Fla., May 14, 2026 /PRNewswire/ — Rochefort Asset Management (Rochefort), a U.S. national security-focused private credit firm licensed under... Read more.
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ — Cypherpunk Technologies Inc., (Nasdaq: CYPH) (“Cypherpunk”), today reported financial results for... Read more.
Veeva Commercial Summit to Feature Biopharma’s AI Successes and the Path to Agentic Commercial
argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, Novo Nordisk, Takeda, and Vertex share how they are redefining engagement across sales, marketing,... Read more.
Iridium to Acquire Aireon, Advancing its Strategy to Lead the Future of Aviation Safety
The transaction unifies the world’s only space-based air traffic surveillance system with the satellite network it was built on and extends commercial partnerships... Read more.
Anduril Industries Named Flagship Sponsor of BlueTIDE 2026
Advancing Integration of Emerging Technologies into Defense Platforms NEWPORT, R.I., May. 14, 2026 /PRNewswire/ — Polaris Tech Bridge (formerly 401 Tech Bridge)... Read more.
BCE to participate in the J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston
MONTRÉAL, May 14, 2026 /CNW/ – Curtis Millen, Executive Vice President and Chief Financial Officer of BCE Inc. (TSX: BCE) (NYSE: BCE) will participate in... Read more.
Cybersecurity / AI Executive Roundtable Delves into Companies’ Challenges in Addressing Evolving Cyber Threats
CHICAGO, May 14, 2026 /PRNewswire/ — An Executive Roundtable exploring the challenges companies are facing on evolving cybersecurity threats, ransomware and... Read more.
GEMMABio Unveils Duchenne Muscular Dystrophy (DMD) Program and Presents Preclinical Data for Next‑Generation Gene Therapies for DMD and Spinal Muscular Atrophy Type 1 (SMA1) at the ASGCT 2026 Annual Meeting
-DMD preclinical data support candidate declaration for GB703, a potential DMD gene therapy designed to broaden mutation coverage and improve muscle delivery-SMA1... Read more.